OLFC On Other Exchanges

olfactory biosciences corp (OLFC) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

olfactory biosciences corp (OLFC) Related Businessweek News

No Related Businessweek News Found

olfactory biosciences corp (OLFC) Details

Olfactory Biosciences Corp., a life sciences company, focuses on designing pharmaceutical products using natural phytochemicals and phytonutrients. The company provides NOXO Odor Defense Pro that prevents the symptoms associated with noxious odors, such as nausea, retching, malaise, and repulsion; HungerMgmt, which prevents overeating; Nootravate, a balm that enhances the memory; and Exanstres, a balm, which controls and reduces harmful stress. It also offers Sambigan for natural night’s sleep; emoodal, a mood booster; Somaklin, which reduces anxiety associated with panic attacks, shortness of breath, dizziness, and hot flashes and/or chills; Studibuddy that enhances memory, alertness, and concentration; and Sensopath, a gel which stops hypersensitivities and reduces copying behaviors. Olfactory Biosciences Corp. was founded in 1999 and is based in Wynnewood, Pennsylvania.

olfactory biosciences corp (OLFC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

olfactory biosciences corp
Olfactory Biosciences Corp. Announces New NOXO Sensory Spectrum Disorders Gel

Olfactory Biosciences Corp. announced new NOXO Sensory Spectrum Disorders Gel(TM). Sensory MeLtdowns are Neurological. A child with sensory processing disorder or autism may find that meLtdowns are eliminated with NOXO Sensory Spectrum Disorders Gel(TM), or it has helped improve behavior and social engagement. New NOXO Sensory Spectrum Disorders Gel(TM) contains therapeutic natural ingredients, which are delivered to the brain through the olfactory receptors after topical application under the nose. Once NOXO Sensory Spectrum Disorders Gel(TM) is inhaled, the NOXO molecules transport their "messages" directly to the brain's emotional center - the limbic system, and there is an improvement in sensory messaging processing.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

OLFC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OLFC.
View Industry Companies

Industry Analysis


Industry Average

Valuation OLFC Industry Range
No financial data is available for OLFC.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OLFACTORY BIOSCIENCES CORP, please visit www.noxoinfo.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.